Literature DB >> 26193052

Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults: a meta-analysis.

Shivank A Madan1, Febin John, Nikolaos Pyrsopoulos, Capecomorin S Pitchumoni.   

Abstract

Observational studies suggest that nonalcoholic fatty liver disease (NAFLD) is associated with increased carotid intimal medial thickness (C-IMT) and carotid plaques in both children and adults. We carried out a meta-analysis to evaluate the relationship between NAFLD and carotid atherosclerosis measured as C-IMT and carotid plaque prevalence. Medline (Ovid), PubMed, Web of Science, and CINAHL databases were searched from 1946 to September 2014, complemented with a manual review of references of the published articles for studies that compared C-IMT or carotid plaque prevalence in adults and children. Results were pooled using both fixed and random effects models. Of the studies identified, 20 were suitable for testing the effect of NAFLD on C-IMT in adults, 13 for testing the effect of NAFLD on carotid plaque prevalence in adults, and five for testing the effect of NAFLD on C-IMT in the pediatric population. The pooled data from 20 studies (19,274 adult participants: NAFLD=8652, controls=10,622) showed significantly increased C-IMT in patients with NAFLD, compared with controls without NAFLD, according to both fixed [standardized mean difference (SMD)=0.251, 95% confidence interval (CI): 0.220-0.282, P<0.001] and random effects models (SMD=0.944, 95% CI: 0.728-1.160, P<0.001). NAFLD was also found to be associated with a higher carotid artery plaque prevalence when compared with controls, according to both fixed (OR=1.273, 95% CI=1.162-1.394, P<0.001) and random effects models (OR=1.769, 95% CI: 1.213-2.581, P=0.003), on pooling of 13 studies (14,445 adult participants: NAFLD=5399 and controls=9046). Analysis of pooled data from five studies in the pediatric population (1121 pediatric participants: NAFLD=312 and controls=809) also found NAFLD to be associated with significantly increased C-IMT according to fixed (SMD=0.995, 95% CI: 0.840-1.150, P<0.001) and random effects models (1.083, 95% CI: 0.457-1.709, P=0.001). NAFLD is associated with increased C-IMT in both children and adults, and with increased carotid plaque prevalence in adults. Individuals identified with carotid disease should be evaluated for NAFLD and vice versa.

Entities:  

Mesh:

Year:  2015        PMID: 26193052     DOI: 10.1097/MEG.0000000000000429

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  33 in total

Review 1.  Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis.

Authors:  Luan Rodrigues Abdallah; Ricardo Cardoso de Matos; Yves Pacheco Dias March E Souza; Débora Vieira-Soares; Gabriela Muller-Machado; Priscila Pollo-Flores
Journal:  Curr Atheroscler Rep       Date:  2020-02-04       Impact factor: 5.113

2.  Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke.

Authors:  Neal S Parikh; Lisa B VanWagner; Mitchell S V Elkind; Jose Gutierrez
Journal:  J Neurol Sci       Date:  2019-10-13       Impact factor: 3.181

3.  Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans.

Authors:  Clarence Gill; Kristina P Vatcheva; Jen-Jung Pan; Beverly Smulevitz; David D McPherson; Michael Fallon; Joseph B McCormick; Susan P Fisher-Hoch; Susan T Laing
Journal:  Am J Cardiol       Date:  2017-03-16       Impact factor: 2.778

Review 4.  Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease.

Authors:  Peter Mirtschink; Cholsoon Jang; Zoltan Arany; Wilhelm Krek
Journal:  Eur Heart J       Date:  2018-07-07       Impact factor: 29.983

Review 5.  Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations.

Authors:  Alexander J Kovalic; George Cholankeril; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-03

6.  Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis.

Authors:  Yanyong Xu; Yang Xu; Yingdong Zhu; Huihui Sun; Cody Juguilon; Feng Li; Daping Fan; Liya Yin; Yanqiao Zhang
Journal:  Mol Ther       Date:  2019-09-12       Impact factor: 11.454

7.  Association between PNPLA3 rs738409 G variant and MRI cerebrovascular disease biomarkers.

Authors:  Neal S Parikh; Nicole Dueker; Dalila Varela; Victor J Del Brutto; Tatjana Rundek; Clinton B Wright; Ralph L Sacco; Mitchell S V Elkind; Jose Gutierrez
Journal:  J Neurol Sci       Date:  2020-06-20       Impact factor: 3.181

8.  Liver Fibrosis is Associated with Ischemic Stroke Risk in Women but not Men: The REGARDS Study.

Authors:  Neal S Parikh; Insu Koh; Lisa B VanWagner; Mitchell S V Elkind; Neil A Zakai; Mary Cushman
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-04-16       Impact factor: 2.677

9.  Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals.

Authors:  Ansel Shao Pin Tang; Kai En Chan; Jingxuan Quek; Jieling Xiao; Phoebe Tay; Margaret Teng; Keng Siang Lee; Snow Yunni Lin; May Zin Myint; Benjamin Tan; Vijay K Sharma; Darren Jun Hao Tan; Wen Hui Lim; Apichat Kaewdech; Daniel Huang; Nicholas Ws Chew; Mohammad Shadab Siddiqui; Arun J Sanyal; Mark Muthiah; Cheng Han Ng
Journal:  Clin Mol Hepatol       Date:  2022-03-02

10.  AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects.

Authors:  Carlo De Matteis; Marica Cariello; Giusi Graziano; Stefano Battaglia; Patrizia Suppressa; Giuseppina Piazzolla; Carlo Sabbà; Antonio Moschetta
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.